NCT03320824已完成不适用
A Randomized, Controlled, Evaluator-Blinded, Multi-Center Study to Evaluate the Effectiveness and Safety of Restylane Kysse Versus a Control in the Augmentation of Soft Tissue Fullness of the Lip
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Galderma R&D
- 入组人数
- 273
- 试验地点
- 28
- 主要终点
- Assess Effectiveness of the Treatment Using the Medicis Lip Fullness Scale (MLFS)
研究概览
简要总结
To demonstrate non-inferiority of Kysse versus a control in lip fullness augmentation
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 22 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subjects willing to comply with the requirements of the study and providing a signed written informed consent.
- •Males or non-pregnant, non-breastfeeding females, 22 years of age or older.
- •Seeking augmentation therapy for the lips
排除标准
- •Allergy of hypersensitivity to any injectable hyaluronic acid gel or to gram positive bacterial proteins.
- •Allergy or hypersensitivity to lidocaine or other amide-type anesthetics, or topical anesthetics or nerve blocking agents.
结局指标
主要结局
Assess Effectiveness of the Treatment Using the Medicis Lip Fullness Scale (MLFS)
时间窗: 8 weeks after last injection
The MLFS is a validated photograph-based outcome instrument that is designed specifically for quantifying lip fullness. Scoring of lip fullness (grades 0-5, with a higher score reflecting greater lip fullness) was based on visual live assessment by the Blinded Evaluator at defined time points, and not on a comparison to the baseline appearance. Effectiveness is defined as change from baseline at 8 weeks after last injection of New Dermal Filler or Dermal Filler (control).
次要结局
- Assess Effectiveness of the New Dermal Filler Treatment in the Upper & Lower Lips Using the Medicis Lip Fullness Scale(16, 24, 32, 40, and 48 weeks)
- Assess Aesthetic Improvement in the Perioral Rhytids & Oral Commissures After New Dermal Filler Treatment Using the Wrinkle Assessment Scale (Change From Baseline, Blinded Evaluator)(8, 16, 24, 32, 40, and 48 weeks after last injection)
- Assess Overall Aesthetic Improvement After New Dermal Filler Treatment Using the Global Aesthetic Improvement Scale Determined by Response Rates, Subject Assessment(8, 16, 24, 32, 40, and 48 weeks)
- Assess Subject Satisfaction With New Dermal Filler Treatment Using the FACE-Q(8, 16, 24, 32, 40, and 48 weeks)
- Assess Aesthetic Improvement in the Perioral Rhytids & Oral Commissures After New Dermal Filler Treatment Using the Wrinkle Assessment Scale (Response Rates, Blinded Evaluator)(8, 16, 24, 32, 40, and 48 weeks)
- Assess Overall Aesthetic Improvement After New Dermal Filler Treatment Using the Global Aesthetic Improvement Scale, Treating Investigator(8, 16, 24, 32, 40, and 48 weeks)
- Assessment of Improvement in Lip Fullness After New Dermal Filler Treatment, by Independent Photographic Reviewer(8, 24, 40, and 48 weeks)
研究者
研究点 (28)
Loading locations...
相似试验
已完成
不适用
Safety/Efficacy Study of Restylane® in Lip AugmentationLip AugmentationNCT00935272Medicis Global Service Corporation180
已完成
不适用
Effectiveness of Full-thickness Palatal Graft Technique (FTPGT) in Obtaining Complete Root CoverageGingival RecessionNCT04028037G. d'Annunzio University40
已完成
不适用
Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin ProfileChin AugmentationChin RetrusionNCT05777759Galderma R&D175
已完成
不适用
Clinical Trial Comparing Two Non-Surgical Treatments for Severe BlepharoptosisBlepharoptosisPtosis, EyelidTraumatic Brain InjuryChronic Progressive External OphthalmoplegiaStrokeMyasthenia GravisNCT04678115Massachusetts Eye and Ear Infirmary16
已完成
不适用
Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.Atopic Dermatitis EczemaNCT03268174AOBiome LLC19